Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Bone & Joint Health Supplements Market

Bone & Joint Health Supplements Market Size

  • Report ID: GMI7684
  • Published Date: Dec 2023
  • Report Format: PDF

Bone & Joint Health Supplements Market Size

Bone & Joint Health Supplements Market size was valued to be around USD 13.6 billion in 2023 and is anticipated to grow at a CAGR of 7.5% from 2024 to 2032. The increasing ageing population, rising prevalence of bone-related disorders, and growing awareness & demand for dietary supplements are the significant contributors to the considerable gains of this industry.

 

For instance, according to the Consumer Survey on Dietary Supplements 2022 conducted by Council for Responsible Nutrition, nearly 75% of Americans use dietary supplements among which majority of users are regular users of dietary supplements including bone & joint supplements. This surge in consumption of nutraceutical products such as dietary supplements and a heightened emphasis on preventive healthcare contribute significantly to the escalating demand for these products.
 

Bone and joint health supplements are dietary products formulated to support and promote the well-being of the skeletal system, particularly bones and joints. These supplements typically contain a combination of vitamins, minerals, and other bioactive compounds that help to contribute to bone density, joint flexibility, and overall musculoskeletal health.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for bone & joint health supplements was valued at USD 13.6 billion in 2023 and is anticipated to observe over 7.5% CAGR from 2024 to 2032 attributed to the increasing ageing population and the rising prevalence of bone-related disorders.

The vitamins & minerals segment accounted for a significant market share of 50.1% in 2023 and will grow significantly through 2032 as they are easily accessible and affordable, making them more widely available to a diverse consumer base.

North America market size was USD 5.2 billion in 2023 and is expected to expand by 2032 with the growing geriatric population along with the higher prevalence of bone and joint health issues, such as osteoporosis and arthritis.

Bayer AG, Amway, BASF SE, Vita Life Sciences Ltd, Glanbia plc, Arazo Nutrition, Reckitt Benckiser Group plc, Nature's Bounty, Inc., NOW Foods, and GNC Holdings, LLC.

Bone & Joint Health Supplements Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 270
  • Countries covered: 19
  • Pages: 150
 Download Free Sample